Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Charlotte Engebrecht"'
Autor:
Anika Varma, Jennifer Weinstein, Jamison Seabury, Spencer Rosero, Nuran Dilek, John Heatwole, Charlotte Engebrecht, Shaweta Khosa, Kaitlin Chung, Asif Paker, Amy Woo, Gregory Brooks, Chan Beals, Rohan Gandhi, Chad Heatwole
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-22 (2024)
Abstract Background Adrenoleukodystrophy (ALD) is a multifaceted, X-linked, neurodegenerative disorder that comprises several clinical phenotypes. ALD affects patients through a variety of physical, emotional, social, and other disease-specific facto
Externí odkaz:
https://doaj.org/article/b05f6dc5d6844e1eb9c2b11d419d422b
Autor:
Anika Varma, Jennifer Weinstein, Jamison Seabury, Spencer Rosero, Nuran Dilek, John Heatwole, Charlotte Engebrecht, Shaweta Khosa, Kaitlin Chung, Asif Paker, Amy Woo, Gregory Brooks, Chan Beals, Rohan Gandhi, Chad Heatwole
Background Adrenoleukodystrophy (ALD) is a multifaceted, x-linked, neurodegenerative disorder that affect patients through a variety of physical, emotional, social, and other disease-specific factors that collectively contribute to disease burden. Ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ff9e97c5ddb75955bb72f0c0212cf7d
https://doi.org/10.21203/rs.3.rs-2856459/v1
https://doi.org/10.21203/rs.3.rs-2856459/v1
Autor:
Spencer Rosero, Anika Varma, Jamison Seabury, Jennifer Weinstein, Ellen Wagner, Christine Zizzi, Charlotte Engebrecht, Aaron Kaat, Elizabeth Luebbe, Nuran Dilek, John Heatwole, Lawrence Saubermann, Larissa Temple, Scott Rogoff, Chad Heatwole
Publikováno v:
Inflammatory Bowel Diseases. 29:S74-S75
STUDY AIM To bolster Crohn’s disease (CD) clinical trial and research infrastructure through the development and validation of a sensitive, multifactorial, disease-specific, patient-reported outcome measure (PRO) for patient monitoring in therapeut
Autor:
Anika Varma, Spencer Rosero, Jamison Seabury, Jennifer Weinstein, Charlotte Engebrecht, Christine Zizzi, Nuran Dilek, John Heatwole, Megan Baumgart, Deborah Mulford, Ronald Maggiore, Lainie Conrow, Jennifer King, Jacinta Wiens, Chad Heatwole
Publikováno v:
Cancer Research. 83:4383-4383
Study Aim: The goal of this research is to develop and validate a novel, disease-specific patient-reported outcome measure (PRO) for use in clinical monitoring and therapeutic trials in Lung Cancer (LC). Methods: LC currently accounts for the greates